Research chair named after Dr. Salem
St. Luke’s Episcopal Hospital has established the Philip A. Salem, MD, Chair in Cancer Research.
PHILIP A. SALEM, MD
St. Luke's Episcopal Hospital has established the Philip A. Salem, MD, Chair in Cancer Research. This is the first chair in cancer research established at the Houston-based hospital which is part of the Texas Medical Center.
Dr. Salem is the director of the cancer research program at St. Luke's. His groundbreaking work in chemoprevention, including the link between chronic gastrointestinal infections and the risk of cancer, has led to research focusing on isolating and treating precancerous infections.
Articles in this issue
PSA test drives diagnosis within families
New RT journal calls for papers
Oral Bisphosphonates Not Linked to Esophageal Cancer Risk
Partnering of chemotherapy and radiation yields great response rates in H&N ca, but has not improved survival
Should radiation therapy plus hormone therapy be the new standard of care for locally advanced prostate cancer?
Zoledronic acid plus standard therapy offers anticancer effect in multiple myeloma
Ipilimumab put on fast track by FDA
Who's News
ASTRO releases breast RT guide
Research chair named after Dr. Salem
Breast Cancer Specialists Brace for FDA Word on Avastin
Influx of Funding Impels Collaborative Explorations to Study Sarcoma as Behavior Model for Other Cancers
ASTRO guideline sets standard for use of radiotherapy as palliative treatment of pain from bone metastases
Study supports earlier colon cancer screening for men, but not African Americans
Bone marrow procedures move into the 21st century
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Recent Videos
Related Content
